Increased Intestinal Microbial Diversity Following Fecal Microbiota Transplant for Active Crohn's Disease.
about
A Possible Role of Intestinal Microbiota in the Pathogenesis of Ankylosing SpondylitisFecal Microbiota Transplantation: From Clostridium difficile to Inflammatory Bowel Disease.Multiple fresh fecal microbiota transplants induces and maintains clinical remission in Crohn's disease complicated with inflammatory mass.Antibiotics, gut microbiota, environment in early life and type 1 diabetes.The Present Status of Fecal Microbiota Transplantation and Its Value in the Elderly.The potential role of fecal microbiota transplantation in the treatment of inflammatory Bowel disease.Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease.A Microbiome Foundation for the Study of Crohn's Disease.Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.Clinical Evidence for the Microbiome in Inflammatory Diseases.Purinergic signaling during intestinal inflammation.Update on intestinal microbiota in Crohn's disease 2017: Mechanisms, Clinical application, Adverse reactions and Outlook.The Risk of Inflammatory Bowel Disease Flares after Fecal Microbiota Transplantation: Systematic Review and Meta-Analysis.Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis.Butyrate-producing bacteria supplemented in vitro to Crohn's disease patient microbiota increased butyrate production and enhanced intestinal epithelial barrier integrity.Assessment of therapeutic response in Crohn's disease using quantitative dynamic contrast enhanced MRI (DCE-MRI) parameters: A preliminary study.Vancomycin in Very-Early Onset Inflammatory Bowel Disease-Dysbiosis: Fight Fire with Fire?The current therapeutic options for Crohn's disease: from medical therapy to intestinal transplantation.Novel therapeutic concepts for inflammatory bowel disease-from bench to bedside.Durability and Long-Term Clinical Outcomes of Fecal Microbiota Transplant (FMT) Treatment in Patients with Recurrent Clostridium difficile Infection.The Value of Fecal Microbiota Transplantation in the Treatment of Ulcerative Colitis Patients: A Systematic Review and Meta-Analysis.Fecal microbiota transplant - a new frontier in inflammatory bowel diseaseProtocol for Fecal Microbiota Transplantation in Inflammatory Bowel Disease: A Systematic Review and Meta-AnalysisThe Safety of Fecal Microbiota Transplantation for Crohn's Disease: Findings from A Long-Term Study
P2860
Q28069331-F0908EE0-96BF-442C-A827-825CA26A755EQ33717111-6ABF6833-045C-4532-B752-CC040C57EA63Q33881185-D32E2B6C-CA19-45DD-8D39-108F3A707FC8Q36277657-AD20EA4F-986A-4DC0-8684-21D223978ED3Q38658559-0A954CA5-0304-4AD1-AEC9-EB402B25EBB8Q38661453-CD54F83A-8F7E-42ED-B741-CE6D45EBE142Q38727911-7AF5095C-C49E-4B2F-9C2E-DB32703250F9Q38748011-6BDC5DD1-8332-4CE5-846E-16FA6A23C01AQ38795652-0A09C7D0-497E-4C87-A632-CBE26925F7F1Q39265428-B21CD0BD-D818-4359-AC02-191E2BEB934DQ39331824-1468DF1F-231C-4022-BC93-285C5DE1E7DCQ39414517-DF00EC11-4A77-4993-95EB-AC0C1629F9BEQ39444977-3DD426D3-0A61-41B0-9361-580ED3C8BE3CQ40227125-B2401213-2604-470D-896B-0B1AE3425683Q41127262-DFF96736-3B8B-4731-A515-6C625317F2C1Q41390534-A0F35D36-B95D-4F9A-9E8C-C570B1D0157AQ47686862-97E57824-DAE8-4370-A4CE-297F4D63BC67Q47798734-4635BF5C-C022-454A-BDBB-B3B67D830113Q48286065-B87CE96C-67A0-4EE1-85B0-DDA2A9E5B77CQ49617141-6D7BFD5B-56CE-4A23-9CD0-5F3E7D070811Q55304582-CD3B7C80-C258-4172-87A5-4EBFF1C68F34Q57166529-17B8A3CC-3FDD-4A43-8AF8-72A0B3906784Q57300359-5937266A-C3E4-4469-8D54-3989E52937DBQ57455312-D629012E-3A25-494A-99C1-92CFA26D814D
P2860
Increased Intestinal Microbial Diversity Following Fecal Microbiota Transplant for Active Crohn's Disease.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Increased Intestinal Microbial ...... nt for Active Crohn's Disease.
@en
type
label
Increased Intestinal Microbial ...... nt for Active Crohn's Disease.
@en
prefLabel
Increased Intestinal Microbial ...... nt for Active Crohn's Disease.
@en
P2093
P2860
P1476
Increased Intestinal Microbial ...... nt for Active Crohn's Disease.
@en
P2093
Aiping Bai
Alan C Moss
Amanda Ting
Dirk Gevers
Jessica R Allegretti
Joshua Korzenik
Ramnik J Xavier
Simon C Robson
P2860
P304
P356
10.1097/MIB.0000000000000893
P577
2016-09-01T00:00:00Z